Search results
Results from the WOW.Com Content Network
The Medical CBRN (Chemical, Biological, Radiological and Nuclear) Defense Consortium, a DOD initiative within its Joint Program Executive Office for Chemical and Biological Defense has awarded the company US$20 million to develop an auto-injector to administer diazepam.
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) [1] is a sub-office of the ASA(ALT).. The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense is the Joint Service’s lead for development, acquisition, fielding and life-cycle support of chemical, biological, radiological and nuclear defense equipment ...
The stock has returned just 1.73% year to date, but analysts expect gains of about 20% in the year ahead. 8. Howmet Aerospace Inc. (HWM) Price: $99.72. Market Cap: $40.82 billion. Dividend Yield ...
The United States Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC) is the United States Department of Defense's principal research and development resource for non-medical chemical and biological defense (CB). [1]
Meanwhile, the average defense stock today has an EV/S of 2.2 and a P/S of 1.8. ... the stock sells for a relatively attractive price-to-earnings (P/E) ratio of just 18.2. Relative to its 15.4% ...
Medical Properties Trust (NYSE: MPW) is a prime example of a high-risk, high-reward stock. In just the past three years, the stock price for this real estate investment trust (REIT) has fallen 77%.
Ology Bioservices (previously named Nanotherapeutics, Inc.) is a private, American biopharmaceutical company headquartered in Alachua, Florida.The company was founded with research in nanometer-scale particle technology to develop new drug delivery technologies and increase the efficacy of existing drugs. [3]